Advanced Non-Small Cell Lung Cancer Patients With Low Tumor Mutation Burden Might Derive Benefit From Immunotherapy.
Nie W, Xu MD, Gan L, Zhang Y, Qian J, Gu K, Zhang XY, Wang HM, Yan B, Gu P, Zhang B, Wang SY, Hu F, Li CH, Zhong H, Han BH.
Nie W, et al. Among authors: gan l.
J Immunother. 2020 Jul/Aug;43(6):189-195. doi: 10.1097/CJI.0000000000000318.
J Immunother. 2020.
PMID: 32209830